Author

Andrew M. Ladd

University of Florida HealthORCID 0009-0005-8566-1485Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Assay:flow cytometry· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Holger A. RussiD· 3 shared Jessie M. BarraiD· 3 shared Edward A. PhelpsiD· 2 shared Aaron W. MichelsiD· 1 shared Adrienne E. WideneriD· 1 shared Alexandra E. CuaycaliD· 1 shared Ali H. ShillehiD· 1 shared Amanda D GrodmaniD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 26 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBioengineering

Holger A. RussORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivPreprintJun 10, 2026

Beta cell reactivity defines disease-relevant pancreatic CD8 T cells in type 1 diabetes

Amanda M. Anderson, Laurie G. Landry, Jessie M. Barra…·Maki Nakayama

This study identifies beta cell reactivity as a key feature distinguishing T1D-associated CD8 T cells from other pancreatic T cells.

1 citation

humanflow cytometry

𝕏 PostBluesky

BioengineeringbioRxivPreprintNov 11, 2025

Anti-CD3 microporous annealed particle hydrogel protects stem cell derived beta cells from autoreactive T cells

Adrienne E. Widener, Cameron T. Manson, Jessie M. Barra…·Edward A. Phelps

This study develops a CD3-functionalized hydrogel to protect stem cell-derived beta cells from immune rejection in diabetes therapy.

1 citation

mouseexperimental assay

𝕏 PostBluesky

BioengineeringbioRxivPreprintOct 21, 2025

Inhibition of cell-mediated immunity in type 1 diabetes by beta cell-targeted PD-1 agonists in pancreas tissue slices

Matthew W. Becker, Matthew E. Brown, Katherine Wiseman…·Edward A. Phelps

This study shows that ImmTAAI, a beta cell-targeted PD-1 agonist, inhibits T cell activity in human type 1 diabetes by increasing T cell motility and reducing cytokine secretion.

DOI 10.1101/2025.10.21.683528

humanproteomics

𝕏 PostBluesky